A PYMNTS Company

EU: EC cleared German pharmaceutical scheme

By  |  March 29, 2015

The European Commission on Friday cleared a German scheme that allowed exceptions to be made for pharmaceutical groups whose medicines were subject to price freezes.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Germany introduced price freezes in the form of rebates granted by the producers of certain prescription medicines but also allowed for exemptions if companies could prove that this would put an unacceptable financial burden on them.

    The Commission, which acts as the competition watchdog in the 28-member European Union, said that after an investigation it found no evidence that such exemptions constituted state aid.

     

    Full Content: European Commission

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.